AIkido Pharma - 37 Year Stock Price History | AIKI

Historical daily share price chart and data for AIkido Pharma since 1984 adjusted for splits. The latest closing stock price for AIkido Pharma as of September 27, 2021 is 0.80.
  • The all-time high AIkido Pharma stock closing price was 236410.44 on February 07, 2000.
  • The AIkido Pharma 52-week high stock price is 2.55, which is 218.8% above the current share price.
  • The AIkido Pharma 52-week low stock price is 0.47, which is 41.3% below the current share price.
  • The average AIkido Pharma stock price for the last 52 weeks is 0.93.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
AIkido Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 1.0522 0.8652 2.3500 0.7266 0.8047 -7.88%
2020 0.8193 1.4000 3.2200 0.4889 0.8735 -33.83%
2019 2.5428 3.0875 3.9099 1.0500 1.3200 -51.73%
2018 4.5900 5.8649 8.5423 2.4224 2.7348 -54.04%
2017 5.7858 4.3349 16.6596 3.8674 5.9499 34.62%
2016 7.6560 9.8572 13.0472 3.6974 4.4199 -62.61%
2015 45.4890 87.2602 91.3000 11.3034 11.8205 -86.45%
2014 205.1828 702.9211 702.9211 65.6552 87.2602 -86.60%
2013 672.4483 550.7895 1753.2832 345.0009 651.2195 18.08%
2012 1112.6354 1971.4336 2326.7764 524.3690 551.5166 -70.83%
2011 4907.0229 12281.0618 15836.1060 1890.6371 1890.6371 -83.52%
2010 19725.1602 19229.5573 29733.0970 8507.8672 11473.0972 -37.72%
2009 19048.8233 8078.0300 36196.8137 4039.8230 18421.5927 147.83%
2008 12824.2248 19391.1502 20845.4865 3231.8584 7433.2742 -58.56%
2007 32115.4981 34257.6987 45892.3888 17936.8139 17936.8139 -51.10%
2006 32995.0271 53810.4418 57365.4860 19391.1502 36683.2084 -34.20%
2005 37863.9717 54941.5922 79503.7158 19391.1502 55749.5568 6.15%
2004 80140.8536 102288.3173 120532.1578 43630.0880 52517.6985 -49.53%
2003 115522.7773 118916.2286 145272.0336 84173.7512 104065.8394 -14.13%
2002 109065.1524 171288.4935 171288.4935 58981.4152 121194.6888 -20.97%
2001 132238.4570 84836.2821 180660.8827 83834.4060 153351.6795 89.80%
2000 113313.0583 89894.1405 236410.4395 71197.8398 80796.4592 -9.09%
1999 94988.0366 119174.7773 125234.5117 65138.1054 88876.1051 -19.27%
1998 75512.0501 74736.7247 123214.6002 53535.7338 110093.2553 37.97%
1997 94882.5713 105035.3969 195931.4135 57527.0789 79794.5831 -20.99%
1996 108938.7566 70696.9018 153513.2724 70696.9018 100995.5740 38.89%
1995 61377.0943 38378.3181 206030.9709 34338.4951 72716.8133 80.00%
1994 52583.7464 62617.2559 64637.1673 38378.3181 40398.2296 -33.33%
1993 54785.1090 66657.0788 86856.1936 36358.4066 60597.3444 11.11%
1992 61508.3722 41367.7871 83785.9282 41367.7871 54537.6099 28.57%
1991 49974.3664 13089.0264 187851.7676 11069.1149 42418.1411 250.00%
1990 31480.2805 39913.4508 43387.6986 12119.4689 12119.4689 -68.42%
1989 37742.2063 44438.0525 50497.7870 26258.8492 38378.3181 -13.64%
1988 61780.8688 67626.6363 78776.5477 40398.2296 44438.0525 -33.33%
1987 65569.9992 52517.6985 84836.2821 42418.1411 66657.0788 26.92%
1986 52478.7373 34338.4951 86856.1936 34338.4951 52517.6985 52.94%
1985 23896.5147 22219.0263 48477.8755 16159.2918 34338.4951 54.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.072B $0.000B
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. AIkido Pharma Inc., formerly known as Spherix Incorporated, is based in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29